Where innovation meets capital
Capital Call – Life Sciences
Event summary
Capital Call connects investors to high-potential companies. This highly anticipated program consistently attracts an audience of 200+ VCs and accredited angel investors. Over its history, almost 400 companies have presented at Capital Call.
This event will feature seed and venture-stage life sciences companies, presenting five-minute rapid-fire pitches. Following the presentations, investors will have an opportunity for Q&A with the presenters in breakout rooms.
Presenting Companies
| BrightSpec | KaloCyte | NX Prenatal |
| Cavalon Therapeutics | Kineta | Ori Biotech |
| Demeter Sciences | LynxBio | SciBac |
| Encellin | Microbion Corporation | Vyriad |
| EpicGenetics | Notogen |
For more information or to request an invitation, please email April Franco.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.